• Più Medical completed its acquisition of 60% of Genoa-based Farmacia dell’Aquila on November 3, 2026, for an estimated €3 million.
• Closing payments totaled approximately €1.7 million, following a €300,000 advance; approximately €1 million remains deferred, subject to adjustment by year-end 2026.
• An additional earn-out depends on Italian aesthetic medicine revenue over the 12 months following closing, subject to profitability conditions.
• Sellers retain 40% and remain operationally involved; put and call options cover the remaining stake.
• Farmacia dell’Aquila generated approximately €14.5 million in 2025 revenue, with EBITDA of approximately €500,000 and net financial debt of approximately €1.1 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Piu Medical S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 20349-32-2026_TELEBORSA.pdf), on November 03, 2026, and is solely responsible for the information contained therein.